Lack of access to therapies leaves Canada’s PAH community holding its collective breath

From researcher to patient to advocate: Alanna’s story

Autoimmune encephalitis

Patient Voice spoke with Alanna Yee about the sudden illness that interrupted her career in medical laboratory science and set her on a journey to find answers and treatment—and reclaim her cognitive health.

Rare voices, real change: Community-based advocacy efforts driving big impact

Patient Voice sat down with Beth Vanstone and Alice Williams, rare disease advocates and Ontario Rare Action Group co-founders, to discuss diagnosis, treatment and care gaps — and how grassroots advocacy can drive meaningful change.

In conversation with Gilead Canada’s Christophe Griolet

Industry Voice sat down with Christophe Griolet, General Manager of Gilead Sciences Canada, to discuss how he applies global learnings in a local context, his commitment to health equity, and the incredible promise of personalized medicine.